Mitsubishi Motors CEO on Carlos Ghosn

Mitsubishi Motors CEO on Carlos Ghosn

Mitsubishi Motors Corp. CEO Osamu Masuko speaks to reporters in Tokyo on Jan. 18, 2019. An internal probe has found that former Chairman Carlos Ghosn "illegally" received around 7.82 million euros ($8.9 million) from an overseas joint venture set up with Nissan Motor Co., the latest in a series of financial allegations against him. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000148704
  • Registered date
  • 2019/1/18 18:07:25
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2019 Kyodo News
  • Media size
  • 3968 × 2691 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 820.20(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Osaka Expo pavilion

    Osaka Expo pavilion

    Shiga Gov. Taizo Mikazuki (C) speaks to reporters during a press preview of the Kansai Pavilion, a showcase by nine prefectures, including Shiga Prefecture, from the Kansai region in western Japan for the 2025 World Exposition, on Oct. 23, 2024, ahead of the Expo's six-month run starting in April 2025, on an artificial island in Osaka, western Japan.
      Baseball: MLB Championship Series

      Baseball: MLB Championship Series

      New York Mets manager Carlos Mendoza holds a press conference in Los Angeles on Oct. 19, 2024, ahead of Game 6 the following day of the National League Championship Series against the Los Angeles Dodgers.
        Economy And Business In Poland

        Economy And Business In Poland

        Peppa Pig toys are seen in Krakow, Poland on October 18th, 2024. (Photo by Beata Zawrzel/NurPhoto)
          Paris Motor Show 2024

          Paris Motor Show 2024

          The Paris Motor Show 2024 in Paris, France, on October 14, 2024, features a Ford GT 40 MKI for sale at 319,990 Euros. (Photo by Daniel Pier/NurPhoto)
            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                  BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                    India-Business

                    India-Business

                    Warren Harris, CEO and MD of Tata Technologies, speaks during a press conference about a joint venture between Tata Technologies and BMW Group in Mumbai, India, on October 8, 2024. (Photo by Indranil Aditya/NurPhoto)
                      India-Business

                      India-Business

                      A BMW i7 electric car is seen during a press conference of a joint venture between Tata Technologies and BMW Group in Mumbai, India, on October 8, 2024. (Photo by Indranil Aditya/NurPhoto)